Aging with multiple sclerosis: cognitive, emotional and neuropathological considerations

Vargas Gray, Peter Andrew Arnett

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Although individuals aging with multiple sclerosis (MS) can experience a compounding of their symptoms, in some circumstances they become more adept at coping with aging-related changes. Fortunately, individuals aging with MS often adjust well to aging, particularly if they have sufficient social support. They also do not appear to show accelerated rates of cognitive decline, and rates of some neuropathological changes have been shown to normalize compared with those seen in normal aging. Results are mixed as to whether older MS patients have higher rates of depression.

Original languageEnglish (US)
Pages (from-to)187-194
Number of pages8
JournalNeurodegenerative disease management
Volume4
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Multiple Sclerosis
Social Support
Depression
Cognitive Dysfunction
icodextrin

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{aaf36428cd5c43688d93e54d9962863b,
title = "Aging with multiple sclerosis: cognitive, emotional and neuropathological considerations",
abstract = "Although individuals aging with multiple sclerosis (MS) can experience a compounding of their symptoms, in some circumstances they become more adept at coping with aging-related changes. Fortunately, individuals aging with MS often adjust well to aging, particularly if they have sufficient social support. They also do not appear to show accelerated rates of cognitive decline, and rates of some neuropathological changes have been shown to normalize compared with those seen in normal aging. Results are mixed as to whether older MS patients have higher rates of depression.",
author = "Vargas Gray and Arnett, {Peter Andrew}",
year = "2014",
month = "1",
day = "1",
doi = "10.2217/nmt.14.12",
language = "English (US)",
volume = "4",
pages = "187--194",
journal = "Neurodegenerative disease management",
issn = "1758-2024",
publisher = "Future Medicine Ltd.",
number = "2",

}

Aging with multiple sclerosis : cognitive, emotional and neuropathological considerations. / Gray, Vargas; Arnett, Peter Andrew.

In: Neurodegenerative disease management, Vol. 4, No. 2, 01.01.2014, p. 187-194.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Aging with multiple sclerosis

T2 - cognitive, emotional and neuropathological considerations

AU - Gray, Vargas

AU - Arnett, Peter Andrew

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Although individuals aging with multiple sclerosis (MS) can experience a compounding of their symptoms, in some circumstances they become more adept at coping with aging-related changes. Fortunately, individuals aging with MS often adjust well to aging, particularly if they have sufficient social support. They also do not appear to show accelerated rates of cognitive decline, and rates of some neuropathological changes have been shown to normalize compared with those seen in normal aging. Results are mixed as to whether older MS patients have higher rates of depression.

AB - Although individuals aging with multiple sclerosis (MS) can experience a compounding of their symptoms, in some circumstances they become more adept at coping with aging-related changes. Fortunately, individuals aging with MS often adjust well to aging, particularly if they have sufficient social support. They also do not appear to show accelerated rates of cognitive decline, and rates of some neuropathological changes have been shown to normalize compared with those seen in normal aging. Results are mixed as to whether older MS patients have higher rates of depression.

UR - http://www.scopus.com/inward/record.url?scp=84922480334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922480334&partnerID=8YFLogxK

U2 - 10.2217/nmt.14.12

DO - 10.2217/nmt.14.12

M3 - Review article

C2 - 24832036

AN - SCOPUS:84922480334

VL - 4

SP - 187

EP - 194

JO - Neurodegenerative disease management

JF - Neurodegenerative disease management

SN - 1758-2024

IS - 2

ER -